Ammonia metabolism promoter

US11291649B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11291649-B2
Application numberUS-201816619701-A
CountryUS
Kind codeB2
Filing dateMay 18, 2018
Priority dateJun 7, 2017
Publication dateApr 5, 2022
Grant dateApr 5, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A material which has excellent ammonia metabolism improving effect and is effective for endurance enhancement, anti-fatigue or the like is provided. An ammonia metabolism promoting agent, comprising catechins and ornithine as active ingredients. An endurance enhancing agent, comprising catechins and ornithine as active ingredients. An anti-fatigue agent, comprising catechins and ornithine as active ingredients. An agent for suppressing a reduction in blood glucose level by exercise, comprising catechins and ornithine as active ingredients. An agent for promoting recovery from reduced blood glucose level by exercise, comprising catechins and ornithine as active ingredients. An agent for suppressing a reduction in muscle glycogen by exercise, comprising catechins and ornithine as active ingredients. A muscle endurance enhancing agent, comprising catechins and ornithine as active ingredients. An agent for preventing or ameliorating hyperammonemia, hepatic encephalopathy or chronic fatigue syndrome, comprising catechins and ornithine as active ingredients.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for enhancing endurance, comprising administering effective amounts of catechins and ornithine to a subject in need thereof. 2. The method of claim 1 , wherein the endurance is muscle endurance. 3. The method according to claim 1 , wherein the catechins to ornithine mass ratio is from 1:0.1 to 1:10.

Assignees

Inventors

Classifications

  • A23L33/105Primary

    Plant extracts, their artificial duplicates or their derivatives · CPC title

  • Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P7/00) · CPC title

  • Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title

  • A61K31/353Primary

    3,4-Dihydrobenzopyrans, e.g. chroman, catechin · CPC title

  • Alpha-amino acids, e.g. alanine or edetic acid [EDTA] (betaine A61K31/205; proline A61K31/401; tryptophan A61K31/405; histidine A61K31/4172; peptides not degraded to individual amino acids A61K38/00) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11291649B2 cover?
A material which has excellent ammonia metabolism improving effect and is effective for endurance enhancement, anti-fatigue or the like is provided. An ammonia metabolism promoting agent, comprising catechins and ornithine as active ingredients. An endurance enhancing agent, comprising catechins and ornithine as active ingredients. An anti-fatigue agent, comprising catechins and ornithine as ac…
Who is the assignee on this patent?
Kao Corp
What technology area does this patent fall under?
Primary CPC classification A23L33/105. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Apr 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).